AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.
研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Abstract 6512: BPI-501836: A highly potent small molecule inhibitor targeting KRASG12D mutation
Xiang Yang, Yuan Lu, Renqi Xu, Xiaoqiang Kong, Yongqing Sun, Xingjie Zhu, Xiaoyun Liu,Zhengyao Zou,Haibo Chen, Yanju Liu, Jialing Sun, Han Han,
Cancer Researchno. 6_Supplement (2024): 6512-6512
引用0浏览0引用
0
0
Abstract CT142: Phase 1 study of BPI-23314, a novel BET inhibitor and degrader, in advanced myeloid leukemia (AML)
Mingyuan Sun, Xiangyu Jin, Jing Guo, Xiaoyun Liu, Yan Xu,Hong Lan,Jiabing Wang, Jiangnan Zhen, Jing Yang,Lieming Ding, Junyuan Qi
Cancer Researchno. 7_Supplement (2024)
引用0浏览0引用
0
0
Abstract 6513: Discovery and characterization of a KRASG12C/D/V degrader with potent anti-tumor activity in KRASmut-driven preclinical models
Zhengqing Li, Renqi Xu, Xiaofeng Yang,Zhengyao Zou, Xiaoqiang Kong,Haibo Chen, Yongqing Sun, Ying Zhao, Jing Guo, Cheng Yang, Han Han, Xiaoyun Liu,
Cancer Researchno. 6_Supplement (2024): 6513-6513
引用0浏览0引用
0
0
Abstract 7575: BPI-460372, a covalent, irreversible TEAD inhibitor in Phase I clinical development
Xiaohong Han, Jing Guo, Xiangyu Jin, Lingyin Zhu, Hongling Shen, Xiaofeng Xu, Mengjie Zhang, Xiaoyun Liu, Yanju Liu, Hongke Cheng, Shunna Guo,Lieming Ding,
Cancer Researchno. 6_Supplement (2024): 7575-7575
引用0浏览0引用
0
0
Abstract 6511: BPI-520105, a highly potent, CNS-penetrant 4th generation EGFR inhibitor overcoming major EGFR resistance mutations in NSCLC
Jing Guo, Lijia Liu,Xiangyong Liu,Bang Fu, Guangcan Bai, Changyong Qiu, Wei Ren, Xiaodong Song, Guolong Du, Xiao Sun, Yongchun Zhang, Weidong Cai,
Cancer Researchno. 6_Supplement (2024): 6511-6511
引用0浏览0引用
0
0
Abstract 7583: Discovery of a potent small molecule MALT1 protease inhibitor for the treatment of cancer
Yuzhen Zhou,Bang Fu,Jie Chen, Weidong Cai, Xiao Sun, Yinlong Li, Wei Ren, Qichao Shen, Guolong Du, Xiaojun Zhou,Zhengyao Zou,Haibo Chen,
Cancer Researchno. 6_Supplement (2024): 7583-7583
引用0浏览0引用
0
0
Abstract 6510: BPI-511966,a potent and selective HPK1 inhibitor with robust single-agent efficacy for cancer immunotherapy
Yong Zhang, Xiaoguan Zhu, Wenmao Wu, Zhifang Xia,Zhengyao Zou, Han Han, Cheng Yang,Haibo Chen,Tianyi Ma, Xiaoyun Liu, Jing Guo, Hao Wu,
Cancer Researchno. 6_Supplement (2024): 6510-6510
引用0浏览0引用
0
0
Abstract 495: Discovery of BPI-221351, a potent, selective, orally available, and brain penetrating dual inhibitor of mutant IDH1/2
Hongling Shen,Xiaofeng Xu, Yabin Li, Xizhen Song,Jie Chen, Yunting Bi, Jing Guo, Tongwen Xu,Huijuan Zhang, Lijia Liu,Zhengyao Zou,Jialin Ren,
Cancer Researchno. 7_Supplement (2023): 495-495
引用0浏览0引用
0
0
Discovery of BPI460372, a potent and selective inhibitor of TEAD for the treatment of solid tumors harboring Hippo pathway aberrations
Hongling Shen, Xiaofeng Xu, Hongfei Rong, Xizhen Song, Jinheng Gao,Jie Chen,Di Zhu, Xiangdong Zhao, Jun Tong,Zhengyao Zou, Xiaoyun Liu, Jin Guo,
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
加载更多
作者统计
  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn